Understanding Cancer Survival & Treatment

Evidence-based information on cancer survival rates, treatment options, and costs in Singapore. Data sourced from Singapore Cancer Registry and international databases.

Start Health Profile View Survival Data
Medical Disclaimer

This website provides general information for educational purposes only. It is not intended as medical advice and should not replace consultation with qualified healthcare professionals. Always consult an oncologist for personalized advice regarding your specific condition.

Cancer in Singapore: Key Statistics

Data from Singapore Cancer Registry Annual Report 2022 (2018-2022)

87,716
Total Cases (2018-2022)
48
New Cases Daily
72
Deaths per 100,000
↑ Improved
Overall Survival Trend
Source: Singapore Cancer Registry Annual Report 2022, National Registry of Diseases Office. View Full Report

Select a Cancer Type

Choose a cancer type to view detailed survival rates, treatment options, and cost information. Data reflects Singapore statistics where available.

Prostate Cancer

Male

Most common cancer in Singapore males

7,515
Cases (2018-2022)
89.2%
5-Year Survival

Breast Cancer

Female

Most common cancer in Singapore females

13,193
Cases (2018-2022)
~82%
5-Year Survival

Colorectal Cancer

Both

2nd most common in both genders

12,704
Cases (2018-2022)
~62%
5-Year Survival

Lung Cancer

Both

Top cause of cancer mortality

9,293
Cases (2018-2022)
~26%
5-Year Survival

Liver Cancer

Both

Often diagnosed at advanced stages

~4,500
Cases (2018-2022)
~18%
5-Year Survival

Stomach Cancer

Both

More common in males

~3,200
Cases (2018-2022)
~32%
5-Year Survival

Uterine Cancer

Female

4th most common in females

~3,500
Cases (2018-2022)
~78%
5-Year Survival

Ovarian Cancer

Female

Often detected late due to subtle symptoms

~2,400
Cases (2018-2022)
~45%
5-Year Survival

Lymphoma

Both

Hodgkin and Non-Hodgkin types

~3,800
Cases (2018-2022)
~68%
5-Year Survival

Thyroid Cancer

Female

Highly treatable with excellent prognosis

~2,800
Cases (2018-2022)
~95%
5-Year Survival

Kidney Cancer

Male

More common in males over 60

~1,800
Cases (2018-2022)
~72%
5-Year Survival

Bladder Cancer

Male

Linked to smoking and chemical exposure

~1,600
Cases (2018-2022)
~75%
5-Year Survival

Pancreatic Cancer

Both

Often diagnosed at advanced stage

~1,500
Cases (2018-2022)
~10%
5-Year Survival

Nasopharyngeal Cancer

Male

More common in Chinese ethnicity

~1,400
Cases (2018-2022)
~60%
5-Year Survival

Cervical Cancer

Female

Preventable with HPV vaccination & screening

~1,200
Cases (2018-2022)
~65%
5-Year Survival

Understanding Survival Rates

Survival rates are statistical estimates based on past patient outcomes. They describe the percentage of patients who are alive at a certain time after diagnosis.

Key Terms

  • 5-Year Relative Survival Rate: The percentage of patients who are alive 5 years after diagnosis, compared to the general population.
  • Relative vs. Observed Survival: Relative survival accounts for deaths from other causes, giving a clearer picture of cancer-specific outcomes.
  • Stage at Diagnosis: Early-stage cancers generally have much better survival rates than late-stage cancers.

Important Considerations

  • Statistics are based on large groups - individual outcomes may vary significantly
  • Treatment advances mean survival rates may be improving
  • Your age, overall health, and response to treatment all affect prognosis
  • Statistics cannot predict what will happen in any individual case
Data Sources: Singapore Cancer Registry 2022, SEER (Surveillance, Epidemiology, and End Results) Program, GLOBOCAN 2022

Get Personalized Information

Create a health profile to see how factors like age, gender, and existing health conditions may affect survival statistics.

Start Health Profile